Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial-Reference-Cited by-同舟云学术

Sorafenib and pegylated interferon-α2b in advanced metastatic melanoma: a multicenter phase II DeCOG trial

Published:2011-07 Issue:7 Volume:22 Page:1667-1674
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Egberts F.,Gutzmer R.,Ugurel S.,Becker J.C.,Trefzer U.,Degen A.,Schenck F.,Frey L.,Wilhelm T.,Hassel J.C.,Schadendorf D.,Livingstone E.,Mauch C.,Garbe C.,Berking C.,Rass K.,Mohr P.,Kaehler K.C.,Weichenthal M.,Hauschild A.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/22/7/1667/461284/mdq648.pdf

Reference21 articles.

1. Final version of 2009 AJCC melanoma staging and classification;Balch;J Clin Oncol,2009

2. Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials;Eigentler;Lancet Oncol,2003

3. Randomised trial of interferon alpha-2a as adjuvant therapy in resected primary melanoma thicker than 1.5mm without clinically detectable node metastases. French Cooperative Group on Melanoma;Grob;Lancet,1998

4. Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684;Kirkwood;J Clin Oncol,1996

5. Randomized dose-escalation study evaluating peginterferon alfa-2a in patients with metastatic malignant melanoma;Dummer;J Clin Oncol,2006

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. VEGF/VEGFR axis and its signaling in melanoma: Current knowledge toward therapeutic targeting agents and future perspectives;Life Sciences;2024-05

2. 30 years German Dermatologic Cooperative Oncology Group (DeCOG);JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2021-10-22

3. 30 Jahre Arbeitsgemeinschaft Dermatologische Onkologie (ADO);JDDG: Journal der Deutschen Dermatologischen Gesellschaft;2021-10-22

4. Treatment of Advanced Melanoma: Past, Present and Future;Life;2020-09-16

5. Treatment of NRAS-mutated advanced or metastatic melanoma: rationale, current trials and evidence to date;Therapeutic Advances in Medical Oncology;2017-05-29